NOP58

Nucleolar protein 58 · Q9Y2X3 · NOP58 on Sugi Atlas →

0 patent compounds predicted against NOP58, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NOP58 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) PHASE3COMPLETED
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors PHASE1/PHASE2RECRUITING
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema PHASE2COMPLETED
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant PHASE2COMPLETED
Nucleoside Therapy in Patients With Telomere Biology Disorders PHASE1RECRUITING
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma nanWITHDRAWN
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Identification of New FTLD Genes nanUNKNOWN
Impact of Bariatric and Metabolic Surgery on the Reduction of Premature Aging. nanCOMPLETED
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy nanCOMPLETED
Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) nanCOMPLETED
ASO Treatment for Syndromic Craniosynostoses nanNOT_YET_RECRUITING
Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization Technique nanUNKNOWN
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a NOP58 binder may also engage these)

ProteinNameSimilarity
Q4R779 1.000 Q4R779 →
Q9MAB3 1.000 Q9MAB3 →
Q6DFW4 1.000 Q6DFW4 →
Q9QZ86 1.000 Q9QZ86 →
Q8X066 0.998 Q8X066 →
Q12460 0.998 Q12460 →
Q95K50 0.997 Q95K50 →
Q3SZ63 0.996 Q3SZ63 →
Q5RA29 0.996 Q5RA29 →
A6ZPE5 0.996 A6ZPE5 →
Q9P7S7 0.996 Q9P7S7 →
Q59S06 0.996 Q59S06 →
Q6CG46 0.995 Q6CG46 →
NOP56 Nucleolar protein 56 0.995 landscape →
Q9D6Z1 0.995 Q9D6Z1 →
A1D688 0.994 A1D688 →
O04658 0.994 O04658 →
Q12499 0.994 Q12499 →
Q753I4 0.994 Q753I4 →
Q6FQ21 0.994 Q6FQ21 →
Q6CKR8 0.994 Q6CKR8 →
A6RMY5 0.994 A6RMY5 →
A7F2R6 0.993 A7F2R6 →
P0CP26 0.993 P0CP26 →
A1CL70 0.993 A1CL70 →
A7TIF5 0.992 A7TIF5 →
A2QE38 0.992 A2QE38 →
Q5B8G3 0.992 Q5B8G3 →
Q4WYK9 0.992 Q4WYK9 →
A3LUT0 0.992 A3LUT0 →